Fundz

MediWound Announces Appointment of Shmulik Hess, Ph.D. as Chief Operating Officer and Chief Commercial Officer

PUBLIC · MDWDNov 21, 2023

Position

Chief Commercial Officer

Company

MediWound Ltd

Shmulik Hess
shmulikh@mediwound.com
IsraelBiotechnologyHealthcareHealth CareTherapeutics

Description

MediWound Ltd. , a fully-integrated biopharmaceutical company focused on next-generation enzymatic therapeutics for tissue repair, today announced the appointment of Shmulik Hess, Ph.D. to the positions of Chief Operating Officer and Chief Commercial Officer effective as of December 1, 2023.

Quick answer

MediWound Announces Appointment of Shmulik Hess, Ph.D. as Chief Operating Officer and Chief Commercial Officer (November 21, 2023). MediWound Ltd is based in Israel.

Who is the new Chief Commercial Officer at MediWound Ltd?
MediWound Ltd named Shmulik Hess Chief Commercial Officer, announced November 21, 2023.
What did MediWound Ltd announce on November 21, 2023?
MediWound Ltd. , a fully-integrated biopharmaceutical company focused on next-generation enzymatic therapeutics for tissue repair, today announced the appointment of Shmulik Hess, Ph.D. to the positions of Chief Operating Officer and Chief Commercial Officer effective as of December 1, 2023.
What does MediWound Ltd do?
MediWound Ltd. (Nasdaq: MDWD) is the global leader in next-generation enzymatic therapeutics focused on non-surgical tissue repair.
Where is MediWound Ltd based?
MediWound Ltd is based in Israel.
Which similar companies made leadership changes around the same time?
Madrigal Pharmaceuticals (November 21, 2023), CytoDyn (November 21, 2023), Chimerix (November 16, 2023) and Amylyx Pharmaceuticals (November 28, 2023) also announced leadership changes within 45 days of MediWound Ltd.

Source: Fundz verified event record.

Other recent leadership changes in Healthcare and Therapeutics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at MediWound Ltd, and when

A new leader at MediWound Ltd brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day MediWound Ltd raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at MediWound Ltd, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at MediWound Ltd. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

MediWound Ltd

Location

42 HAYARKON STREET

Israel

About

MediWound Ltd. (Nasdaq: MDWD) is the global leader in next-generation enzymatic therapeutics focused on non-surgical tissue repair. Specializing in the development, production and commercialization of solutions that seek to replace existing standards of care, the Company is committed to providing rapid and effective biologics that improve patient experiences and outcomes, while reducing costs and unnecessary surgeries. MediWound’s first drug, NexoBrid®, is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Utilizing the same core biotherapeutic enzymatic platform technology, MediWound has developed a strong R&D pipeline including the Company’s lead drug under development, EscharEx®. EscharEx is a Phase III-ready biologic for debridement of chronic wounds with significant advantages over the $300 million monopoly legacy drug and an opportunity to expand the market. MediWound’s pipeline also includes MW005, a topical therapeutic for the treatment of basal cell carcinoma that has demonstrated positive results in a recently completed Phase I/II study. For more information visit www.mediwound.com

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment MediWound Ltd changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Shmulik
Likely contact at this company
••••••••@••••••••

See Shmulik's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for MediWound Ltd's next move

Learn about Strategic plan

MediWound Ltd changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.